Similar content being viewed by others Background Chronic migraine (CM) is a severe neurological disease that seriously affects the daily life of patients and imposes a large economic burden on society [1, 2]
The primary endpoint was a composite of death from cardiovascular causes, non-fatal MI or non-fatal stroke, with a significant 20% reduction in the semaglutide group versus placebo
Food and Drug Administration (FDA) for its Group A Streptococcus (GAS) assay, to be used on the LIAISON NES Point-of-Care (POC) molecular diagnostics platform
doi: 10.1016/j.surg.2009.10.016 [DOI] [PMC free article] [PubMed] [Google Scholar] 176
The Association of Anaesthetists , in collaboration with the Royal College of Anaesthetists (RCoA), Centre for Perioperative Care (CPOC), and the Joint British Diabetes Societies (JBDS), has published recommendations addressing the management of patients taking these medications before surgery